abiraterone

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

abiraterone
Dec 22, 2024, 14:32 | Science
10 Top Translational Papers in GU Oncology suggested by Toni Choueiri
Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…
Dec 1, 2024, 21:26 | Blog
Rana McKay: CAPItello-281 phase 3 in PTEN-deficient Metastatic Hormone-Sensitive Prostate Cancer
Rana McKay, Associate Professor of Medicine at UC San Diego, shared a post on X:…
Sep 26, 2024, 12:37 | Insight
Exclusive Interview With Fred Saad
MediaMedic shared on LinkedIn: “Exclusive Insights on mHSPC Treatment: Interview with Fred Saad. In a…
Sep 22, 2024, 12:38 | Blog
Amol Akhade: Cabozantinib plus Atezolizumab vs second-line NHT in prostate cancer
Amol Akhade shared a post on LinkedIn: ''Cabozantinib plus Atezolizumab versus second-line Non-hormonal Therapy (NHT)…
Aug 13, 2024, 19:23 | Insight
Earle Burgess: For men with metastatic prostate cancer who are taking abiraterone and prednisone
Earle Burgess, Chief, Genitourinary Oncology Section at Atrium Health Levine Cancer Institute, shared a post…
Aug 10, 2024, 14:33 | Insight
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…
Aug 10, 2024, 12:17 | Insight
Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…
Jul 12, 2024, 16:05 | Insight
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC
Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…
Jun 6, 2024, 10:53 | Insight
Earle Burgess: The best part of the oral prostate cancer session at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “What…
Jun 4, 2024, 04:53 | Insight
Earle Burgess: Fascinating preliminary phase I trial data in mCRPC at ASCO24
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health Levine Cancer Institute, shared a post on LinkedIn:…
May 5, 2024, 01:02 | Blog
Amol Akhade: Does this ring bell for other oral drugs also?
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X: “Optimal…
Aug 25, 2023, 18:22 | Insight
Earle Burgess: Which newly diagnosed metastatic castrate-sensitive prostate cancer patients need to add docetaxel chemotherapy to an ADT + ARPI doublet?
Quoting Earle Burgess, Genitourinary Medical Oncologist and Clinical Researcher at Atrium Health, Levine Cancer Institute,…
All: 12 Posts: 1 - 100
Special Coverage